Trial Profile
A retrospective study to evaluate the clinical outcomes of Ipilimumab in patients with acral melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 29 Mar 2016 New trial record